A DNAzyme-catalyzed label-free aptasensor based on multifunctional dendrimer-like DNA assembly for sensitive detection of carcinoembryonic antigen.

Biosens Bioelectron

Department of Molecular Pathology, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, 450001, China; Henan Key Laboratory of Molecular Pathology, Zhengzhou, 450001, China.

Published: December 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Carcinoembryonic antigen (CEA) is an important malign tumor marker. In this study, a simple, label-free and antibody-free aptasensor was fabricated based on a multifunctional dendrimer-like DNA nanoassembly. The DNA nanoassembly was embedded with multiple G-quadruplex DNAzyme motifs and a hanging CEA aptamer motif. It was prepared from short DNA sequences by autonomous-assembly. The aptasensor was prepared simply by self-assembly of a capture DNA (cpDNA) on a gold electrode, followed by hybridization with a CEA aptamer (AptGAC-P). CEA as a model target was detected through competitive binding of CEA with AptGAC-P, exposing cpDNA to bind with the DNA nanoassembly. The detection process only contains 2 incubation steps. The high load of G-quadruplex DNAzyme motifs and their catalytic activity resulted in an amplified and label-free differential pulse voltammetry (DPV) electrochemical signal. The peak current correlated linearly with the CEA concentration, with a linear range of 2-45 ng mL, and an LOD value of 0.24 ng mL. The aptasensor showed high specificity and reproducibility, and retained 96.5% of detection signal intensities after 31 days of storage. The recovery rates for spiked CEA in human serum were within 100 ± 5%, and the coincidence rates for clinical human serum samples with ELISA kits were 80.7-111%. Conceivably, possessing simplicity, sensitivity, reproducibility, storage stability, and accuracy, the aptasensor should be a very prominent and applicable tool for clinical CEA detection and cancer diagnosis, and is promisingly applicable as a platform for detecting other targets of interests.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bios.2021.113618DOI Listing

Publication Analysis

Top Keywords

dna nanoassembly
12
based multifunctional
8
multifunctional dendrimer-like
8
dendrimer-like dna
8
carcinoembryonic antigen
8
cea
8
g-quadruplex dnazyme
8
dnazyme motifs
8
cea aptamer
8
human serum
8

Similar Publications

Low-turnover osteoporosis diagnosis urgently requires sensitive detection of low-abundance osteocalcin (OC), yet conventional methods remain constrained by insufficient sensitivity, cumbersome instrumentation, and laborious operations. We devise a CRISPR-driven pressure bioassay that synergistically integrates molecular recognition, enzymatic amplification, and signal transduction for dual-amplification-enhanced OC quantification. The system features an engineered "locked-to-activated" molecular switch, where target binding liberates CRISPR-activating DNA strands, initiating Cas14a-catalyzed cleavage of ssDNA tethers on FeO-ssDNA-Pt nanoassemblies.

View Article and Find Full Text PDF

Hospital-acquired infections (HAIs) remain a major clinical and economic burden, with pathogens such as Escherichia coli contributing to high rates of morbidity and mortality. Traditional manual disinfection methods are often insufficient, particularly in high-risk hospital environments. In this study, we investigated innovative strategies to enhance surface decontamination and reduce infection risk.

View Article and Find Full Text PDF

Recent Progress in DNA Biosensors: Target-Specific and Structure-Guided Signal Amplification.

Biosensors (Basel)

July 2025

Department of Biotechnology and Bioinformatics, Korea University, Sejong 30019, Republic of Korea.

Deoxyribonucleic acid (DNA) is not only a fundamental biological molecule but also a versatile material for constructing sensitive and specific biosensing platforms. Its ability to undergo sequence-specific hybridization via Watson-Crick base pairing enables both precise target recognition and the programmable construction of nanoscale structures. The demand for ultrasensitive detection increases in fields such as disease diagnostics, therapeutics, and other areas, and the inherent characteristics of DNA have driven the development of a wide range of signal amplification strategies.

View Article and Find Full Text PDF

The clearance of cell-free DNA (cfDNA) in rheumatoid arthritis (RA) represents a promising therapeutic approach for inflammation. While cationic materials are widely utilized for cfDNA capture, their safety during in vivo delivery remains a critical concern. Additionally, macrophage-mediated inflammatory responses exacerbate disease progression.

View Article and Find Full Text PDF

Highly sensitive detection and in situ tracing analysis of small-molecule biomarkers are particularly indispensable to deciphering the pathogenesis and pathological process. Despite DNA assembly-based barcoding and amplification strategies across the breadth of molecular in situ analysis, an easy-to-design, nonenzymatic, highly efficient, background leakage-avoided, highly specific, and sensitive system is highly required yet is still in its infancy. Spatial confinement nano-assembly can increase the reaction efficiency in a localized isothermal autonomous manner.

View Article and Find Full Text PDF